Evidence map›Paper›PMID 39452715›Full record

ArticlePathogens (Basel, Switzerland)2024

Identifying the Impact of

Gabriel Arteaga-Troncoso, Marcela López-Hurtado, Gabino Yescas-Buendía, María J de Haro-Cruz, Iván Alejandro Arteaga-Martínez, Jesús Roberto Villagrana-Zesati, Fernando M Guerra-Infante

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriel Arteaga-TroncosoDepartment of Cellular Biology and Development, Instituto Nacional de Perinatología, Ciudad de Mexico 11000, Mexico.ORCID 0000-0001-9419-9572
Marcela López-HurtadoDepartment of Infectology and Immunology, Instituto Nacional de Perinatología, Ciudad de Mexico 11000, Mexico.
Gabino Yescas-BuendíaNeonatal Intensive Care Unit, Instituto Nacional de Perinatología, Ciudad de Mexico 11000, Mexico.
María J de Haro-CruzDepartment of Veterinary Microbiology, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.ORCID 0000-0003-3258-5608
Iván Alejandro Arteaga-MartínezDepartment of Morphological Sciences and Human Embryology, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.
Jesús Roberto Villagrana-ZesatiDepartment of Gynecology and Obstetrics, Instituto Nacional de Perinatología, Ciudad de Mexico 11000, Mexico.
Fernando M Guerra-InfanteDepartment of Infectology and Immunology, Instituto Nacional de Perinatología, Ciudad de Mexico 11000, Mexico.ORCID 0000-0001-8730-0484

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chlamydia InfectionsChlamydia trachomatisInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdultAnti-Bacterial AgentsCohort StudiesFemaleHumansInfant, NewbornMass ScreeningMexicoPregnancyYoung AdultAnti-Bacterial Agentscase–cohort designChlamydia trachomatishybrid designs in clinical trialsnucleic acid amplification testsprematurityRDS

Identifiers

PMID39452715
PMCPMC11510053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.